Clinically, high expression of HIF-1α and TGF-β1 correlates significantly with advanced TNM stages and lymph node metastasis (Tables 3, 4), suggesting their potential as biomarkers for fibrosis and invasiveness. Here, TGFB1 is linked to metastatic malignant neoplasm in the lymph nodes.